Two years survival of primary cardiac leiomyosarcoma managed by surgical and adjuvant therapy

BACKGROUND: Cardiac tumors are a very rare entity. Leiomyosarcoma represents less than 1% of cases. CASE PRESENTATION: a 51-year-old woman diagnosed with primary left atrium leiomyosarcoma. She was treated by optimal surgery and adjuvant chemotherapy. She is still alive after a follow-up of 24 month...

Descripción completa

Detalles Bibliográficos
Autores principales: Behi, K., Ayadi, M., Mezni, E., Meddeb, K., Mokrani, A., Yahyaoui, Y., Ksontini, F., Rais, H., Chrait, N., Mezlini, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5343408/
https://www.ncbi.nlm.nih.gov/pubmed/28286642
http://dx.doi.org/10.1186/s13569-017-0069-3
Descripción
Sumario:BACKGROUND: Cardiac tumors are a very rare entity. Leiomyosarcoma represents less than 1% of cases. CASE PRESENTATION: a 51-year-old woman diagnosed with primary left atrium leiomyosarcoma. She was treated by optimal surgery and adjuvant chemotherapy. She is still alive after a follow-up of 24 months without evidence of local or distant recurrence. CONCLUSIONS: Cardiac leiomyosarcoma is a rare tumor with a dismal prognosis. Surgery is the mainstay of treatment. Adjuvant treatment is still controversial.

Ejemplares similares